Cargando…

Mobile App and Digital System for Patients after Myocardial Infarction (afterAMI): Results from a Randomized Trial

Cardiac rehabilitation after acute myocardial infarction is crucial and improves patients’ prognosis. It aims to optimize cardiovascular risk factors’ control. Providing additional support via mobile applications has been previously suggested. However, data from prospective, randomized trials evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Krzowski, Bartosz, Boszko, Maria, Peller, Michał, Hoffman, Paulina, Żurawska, Natalia, Skoczylas, Kamila, Osak, Gabriela, Kołtowski, Łukasz, Grabowski, Marcin, Opolski, Grzegorz, Balsam, Paweł
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145296/
https://www.ncbi.nlm.nih.gov/pubmed/37109223
http://dx.doi.org/10.3390/jcm12082886
_version_ 1785034299389509632
author Krzowski, Bartosz
Boszko, Maria
Peller, Michał
Hoffman, Paulina
Żurawska, Natalia
Skoczylas, Kamila
Osak, Gabriela
Kołtowski, Łukasz
Grabowski, Marcin
Opolski, Grzegorz
Balsam, Paweł
author_facet Krzowski, Bartosz
Boszko, Maria
Peller, Michał
Hoffman, Paulina
Żurawska, Natalia
Skoczylas, Kamila
Osak, Gabriela
Kołtowski, Łukasz
Grabowski, Marcin
Opolski, Grzegorz
Balsam, Paweł
author_sort Krzowski, Bartosz
collection PubMed
description Cardiac rehabilitation after acute myocardial infarction is crucial and improves patients’ prognosis. It aims to optimize cardiovascular risk factors’ control. Providing additional support via mobile applications has been previously suggested. However, data from prospective, randomized trials evaluating digital solutions are scarce. In this study, we aimed to evaluate a mobile application—afterAMI—in the clinical setting and to investigate the impact of a digitally-supported model of care in comparison with standard rehabilitation. A total of 100 patients after myocardial infarction were enrolled. Patients were randomized into groups with either a rehabilitation program and access to afterAMI or standard rehabilitation alone. The primary endpoint was rehospitalizations and/or urgent outpatient visits after 6 months. Cardiovascular risk factors’ control was also analyzed. Median age was 61 years; 65% of the participants were male. This study failed to limit the number of primary endpoint events (8% with app vs. 27% without app; p = 0.064). However, patients in the interventional group had lower NT-proBNP levels (p = 0.0231) and better knowledge regarding cardiovascular disease risk factors (p = 0.0009), despite no differences at baseline. This study showcases how a telemedical tool can be used in the clinical setting.
format Online
Article
Text
id pubmed-10145296
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101452962023-04-29 Mobile App and Digital System for Patients after Myocardial Infarction (afterAMI): Results from a Randomized Trial Krzowski, Bartosz Boszko, Maria Peller, Michał Hoffman, Paulina Żurawska, Natalia Skoczylas, Kamila Osak, Gabriela Kołtowski, Łukasz Grabowski, Marcin Opolski, Grzegorz Balsam, Paweł J Clin Med Article Cardiac rehabilitation after acute myocardial infarction is crucial and improves patients’ prognosis. It aims to optimize cardiovascular risk factors’ control. Providing additional support via mobile applications has been previously suggested. However, data from prospective, randomized trials evaluating digital solutions are scarce. In this study, we aimed to evaluate a mobile application—afterAMI—in the clinical setting and to investigate the impact of a digitally-supported model of care in comparison with standard rehabilitation. A total of 100 patients after myocardial infarction were enrolled. Patients were randomized into groups with either a rehabilitation program and access to afterAMI or standard rehabilitation alone. The primary endpoint was rehospitalizations and/or urgent outpatient visits after 6 months. Cardiovascular risk factors’ control was also analyzed. Median age was 61 years; 65% of the participants were male. This study failed to limit the number of primary endpoint events (8% with app vs. 27% without app; p = 0.064). However, patients in the interventional group had lower NT-proBNP levels (p = 0.0231) and better knowledge regarding cardiovascular disease risk factors (p = 0.0009), despite no differences at baseline. This study showcases how a telemedical tool can be used in the clinical setting. MDPI 2023-04-15 /pmc/articles/PMC10145296/ /pubmed/37109223 http://dx.doi.org/10.3390/jcm12082886 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Krzowski, Bartosz
Boszko, Maria
Peller, Michał
Hoffman, Paulina
Żurawska, Natalia
Skoczylas, Kamila
Osak, Gabriela
Kołtowski, Łukasz
Grabowski, Marcin
Opolski, Grzegorz
Balsam, Paweł
Mobile App and Digital System for Patients after Myocardial Infarction (afterAMI): Results from a Randomized Trial
title Mobile App and Digital System for Patients after Myocardial Infarction (afterAMI): Results from a Randomized Trial
title_full Mobile App and Digital System for Patients after Myocardial Infarction (afterAMI): Results from a Randomized Trial
title_fullStr Mobile App and Digital System for Patients after Myocardial Infarction (afterAMI): Results from a Randomized Trial
title_full_unstemmed Mobile App and Digital System for Patients after Myocardial Infarction (afterAMI): Results from a Randomized Trial
title_short Mobile App and Digital System for Patients after Myocardial Infarction (afterAMI): Results from a Randomized Trial
title_sort mobile app and digital system for patients after myocardial infarction (afterami): results from a randomized trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145296/
https://www.ncbi.nlm.nih.gov/pubmed/37109223
http://dx.doi.org/10.3390/jcm12082886
work_keys_str_mv AT krzowskibartosz mobileappanddigitalsystemforpatientsaftermyocardialinfarctionafteramiresultsfromarandomizedtrial
AT boszkomaria mobileappanddigitalsystemforpatientsaftermyocardialinfarctionafteramiresultsfromarandomizedtrial
AT pellermichał mobileappanddigitalsystemforpatientsaftermyocardialinfarctionafteramiresultsfromarandomizedtrial
AT hoffmanpaulina mobileappanddigitalsystemforpatientsaftermyocardialinfarctionafteramiresultsfromarandomizedtrial
AT zurawskanatalia mobileappanddigitalsystemforpatientsaftermyocardialinfarctionafteramiresultsfromarandomizedtrial
AT skoczylaskamila mobileappanddigitalsystemforpatientsaftermyocardialinfarctionafteramiresultsfromarandomizedtrial
AT osakgabriela mobileappanddigitalsystemforpatientsaftermyocardialinfarctionafteramiresultsfromarandomizedtrial
AT kołtowskiłukasz mobileappanddigitalsystemforpatientsaftermyocardialinfarctionafteramiresultsfromarandomizedtrial
AT grabowskimarcin mobileappanddigitalsystemforpatientsaftermyocardialinfarctionafteramiresultsfromarandomizedtrial
AT opolskigrzegorz mobileappanddigitalsystemforpatientsaftermyocardialinfarctionafteramiresultsfromarandomizedtrial
AT balsampaweł mobileappanddigitalsystemforpatientsaftermyocardialinfarctionafteramiresultsfromarandomizedtrial